Zach Hall is Business Development Director at Immusoft, a Seattle-based start-up developing a new paradigm for the delivery of biologic-based medicines in vivo, by turning patient blood cells into drug secreting factories.
Zach has a background in neuroscience, molecular biology, chemistry, and nanoscience. Early entrepreneurial efforts include a medical device to deliver micro-currents of electricity to shrink tumors, a novel drug delivery vesicle derived from autologous cells, and a synthetic orthopedic device for ligament replacement therapy using an advanced carbon composite fiber. Zach is a serial entrepreneur who brings 7+ years of entrepreneurship experience to Immusoft, and has a growing interest in materials science, cancer diagnostics, GMP process development, and electron microscopy.
Recognizing the advantage Immusoft’s ISP™ approach could provide to the current state-of-the-art in drug delivery, Zach joined as the first member of Immusoft’s core team, supporting early grant writing and networking efforts, the creation of the business plan, and provided strategy on how to successfully launch Immusoft. This is Zach’s third biomedical start-up.
To date, Zach has helped Immusoft raise over $650,000 in federal and private research grants, initiated relationships with key vendors and CROs, and is project manager for the Phase I STTR grant through the NIAID with collaborators at the Fred Hutchinson Cancer Research Center (Seattle, WA). He is responsible for managing administrative duties including private and federal grants, purchasing, vendor database management, accounting, technology assessment, special projects, and business development.
Additionally, Zach foresees future applications of ISP™ technology to promote re-myelination for treating neurodegenerative disorders, protection against infectious disease using broadly neutralizing antibodies from rapid antibody discovery platforms, and regenerative medicines to promote healthy bone growth, protection against the effects of lethal radiation, and anti-aging.
He earned a B.S. in Neuroscience and minor in Chemistry from the University of California, Santa Cruz in 2003 where his senior research project at the Santa Cruz Institute of Particle Physics Retina Group characterized electrical signals generated from neural cells responding to patterns of light. Zach attended the UC Berkeley Haas School of Business BioExec Institute Series in 2008, completed the Advanced Project Management course certificate in 2010 from Stanford, and then graduated from the Nanoscience Program from Foothill College in 2012. He went onto work as a Staff Scientist in May of 2012 for the NASA-OMEGA (Off-Shore Membrane Enclosures for Growing Algae), a project aimed at developing a green technology capable of producing scalable quantities of microalgae-based biofuels using nutrients derived from municipal wastewater discharge. Zach is a part-time research scientist at NASA-Ames Research Center Advanced Studies Laboratory (Mountain View, CA).